|
000
| 02831nam 2200469zi 4500 |
|---|
| 001 | 9.916866 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20240904141014 |
|---|
| 006 | m o d f |
|---|
| 007 | cr cn||||||||| |
|---|
| 008 | 221102t20222022oncd obs f000 0 eng d |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 043 | |ay2y2 |
|---|
| 086 | 1 |aCS75-006/2022-11E-PDF |
|---|
| 100 | 1 |aCortes, Kassandra, |eauthor. |
|---|
| 245 | 10|aPharmaceutical access and use during the pandemic / |cby Kassandra Cortes and Leah Smith. |
|---|
| 264 | 1|a[Ottawa] : |bStatistics Canada = Statistique Canada, |c2022. |
|---|
| 264 | 4|c©2022 |
|---|
| 300 | |a1 online resource (12 pages) : |bgraphs. |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 490 | 1 |aInsights on Canadian society, |x2291-0840 |
|---|
| 500 | |aThe publication file in PDF format was replaced on 4 September 2024 at the request of Statistics Canada. |
|---|
| 500 | |aCover title. |
|---|
| 500 | |a"Release date: November 2, 2022." |
|---|
| 500 | |aIssued also in HTML format. |
|---|
| 500 | |aIssued also in French under title: Accès et recours aux produits pharmaceutiques pendant la pandémie. |
|---|
| 504 | |aIncludes bibliographical references (pages 10-12). |
|---|
| 520 | |a"This study examines Canadians' access to and use of pharmaceuticals using data from the 2021 Survey on Access to Health Care and Pharmaceuticals During the Pandemic, collected from March to May 2021. First, it examines the proportion and characteristics of Canadians who reported not having prescription insurance to cover medication costs, as well as those who reported that their prescription insurance was affected by the pandemic. Next, medication use, out-of-pocket spending on prescription medication, and non-adherence to prescription medication because of cost were examined. Analyses are presented across province, immigration status, and racialized groups, among other sociodemographic variables, and thus offers insight into potential inequities in access to pharmaceuticals in Canada"--Overview of the study, page 1. |
|---|
| 650 | 0|aPharmaceutical services insurance|zCanada|vStatistics. |
|---|
| 650 | 0|aDrug utilization|zCanada|vStatistics. |
|---|
| 650 | 0|aCOVID-19 Pandemic, 2020-|zCanada. |
|---|
| 655 | 7|aStatistics|2lcgft |
|---|
| 710 | 2 |aStatistics Canada, |eissuing body. |
|---|
| 775 | 08|tAccès et recours aux produits pharmaceutiques pendant la pandémie / |w(CaOODSP)9.916867 |
|---|
| 830 | #0|aInsights on Canadian society (Statistics Canada)|x2291-0840|w(CaOODSP)9.507406 |
|---|
| 856 | 40|qPDF|s488 KB|uhttps://publications.gc.ca/collections/collection_2022/statcan/75-006-x/75-006-2022-11-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www150.statcan.gc.ca/n1/pub/75-006-x/2022001/article/00011-eng.htm |
|---|